PCa At End of Biopsy Core A Bad Sign

Share this article:

Extracapsular extension found in nearly 60% of men with tumor cells at the end of a needle core.

 

DENVER—The presence of tumor cells at the end of a needle biopsy core obtained near the capsule is an independent indicator of a significantly elevated risk of extracapsular extension, according to data presented here at the annual meeting of the United States and Canada Academy of Pathology.

 

In a study of 185 men who underwent radical prostatectomies who were available for tumor-stage follow-up, Kirk Ke Lin, MD, director of genitourinary pathology at AmeriPath, Inc., discovered that 50.9% of cases with cancerous cells in the end of the needle core near the capsule had stage pT3a or pT3b prostate cancer compared with just 16.2% of cases that did not have cancerous cells and the core's end.

 

Furthermore, 13 of 21 men (61.9%) with prostate cancer at the needle core end who had advanced tumor stage also had perineural invasion. Fifty-five men had prostate cancer cells at the end of the needle biopsy core near the capsule at initial biopsy. Their average PSA level was 8.3 ng/mL compared with 6.6 ng/mL for the 130 patients without tumor cells at the core end.

 

“If these findings are validated in a larger study, it will provide very important information for treatment planning,” Dr. Lin noted. “If the cancer is at the end of a needle core from the right lateral prostate, the surgeon can go around the right lateral prostate to get a clear cut during the prostatectomy. [Or] if there is perineural invasion present in the core-end cancer, a nerve-sparing prostatectomy should not be chosen.”

 

A prominent urologic oncologist, however, questions the importance of the new findings. “I think it's intriguing but I'm skeptical, because there are a lot of potential pitfalls in the way he did the study,” said Peter Scardino, MD, of Memorial Sloan-Kettering Cancer Center in New York, where he is the Florence and Theodore Baumritter/Enid Ancell Chair of Urologic Oncology.

 

“We [already] know that the more cancer there is in a needle biopsy core, the higher the probability a cancer is extracapsular and the higher the Gleason score in the radical prostatectomy specimen. The finding of cancer in one or both ends of a core may simply mean that more cancer was present. We'll have to await further studies before these findings are accepted.”

Share this article:
You must be a registered member of RUN to post a comment.

More in Prostate Cancer

ConfirmMDx Genetic Test Identifies Prostate Cancer Aggressiveness

ConfirmMDx Genetic Test Identifies Prostate Cancer Aggressiveness

New data confirms that ConfirmMDx, an epigenetic assay, is able to accurately identify prostate cancer aggressiveness

Testosterone Replacement Therapy (TRT) May Promote Prostate Tumor Growth

Testosterone Replacement Therapy (TRT) May Promote Prostate Tumor ...

Testosterone replacement therapy (TRT) may promote prostate cancer tumor growth.

High Cholesterol Linked with Prostate Cancer Recurrence

High Cholesterol Linked with Prostate Cancer Recurrence

Findings suggest that normalization of blood fats may reduce risk of prostate cancer.